SciSparc’s (Nasdaq: SPRC) Drug Discovery Joint Venture MitoCareX Bio Successfully Developed its Core Algorithm to allow suitable Modelling of Human Mitochondrial Carriers for Accelerating its Cancer Drug Discovery Program

TEL AVIV, Israel, May 08, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that its joint venture MitoCareX Bio, which focuses on the discovery and development of potential drugs for cancers, rare […]

NanoViricides, Inc. (NYSE American: NNVC)  to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City

SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) — (via IBN) — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which […]

Mawson Infrastructure Group Inc. (NASDAQ:MIGI) Announces $5 Million Registered Direct Offering

SHARON, Pa., May 04, 2023–(BUSINESS WIRE)–Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, today announced a $5 million registered direct offering. Mawson has entered into a definitive agreement with institutional investors for the issuance and sale of 2,083,336 shares of its common stock (or pre-funded warrants in lieu thereof) at […]

OKYO Pharma (NASDAQ: OKYO) Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023

LONDON and NEW YORK, May 03, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, today announced that two presentations will be given on OK-101 at […]

EzFill (NASDAQ: EZFL) Announces 2023 First Quarter Financial Results

— Revenue Increased 123% year over year to $5.2 Million From $2.3 Million — — 1.3 Million Gallons Delivered, Up 122% From Prior Year – — 34 New Fleet Customers Added in Quarter — — Net Loss Narrows by $0.9 Million or $0.29 per share — MIAMI, FL, May 03, 2023 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” or the “Company”) (NASDAQ: EZFL), a pioneer and emerging leader in the mobile fueling industry, announced today its […]

Mawson Infrastructure Group Inc. (NASDAQ: MIGI) to Present at Sidoti Micro Cap Virtual Conference

SHARON, Pa., May 03, 2023–(BUSINESS WIRE)–Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announces Liam Wilson, Chief Operating Officer and Tim Broadfoot, Chief Corporate Officer of Mawson will present at the Sidoti Micro Cap Virtual Conference taking place on May 10th-11th, 2023. Mawson’s presentation will begin at 4:00 p.m. […]

OKYO Pharma (NASDAQ: OKYO) Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease

Trial designed with pre-specified primary efficacy endpoints discussed previously with FDA If successful, this phase 2 trial may serve as one of the two required phase 3 studies necessary to support FDA approval Top-line data from trial anticipated before end of 2023 LONDON and NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.